Suchergebnisse - "Mikus, Gerd"

PubPharm (7)

1

Treatment with rilpivirine does not alter plasma concentrations of the CYP3A substrates tadalafil and midazolam in humans

enthalten in: The journal of antimicrobial chemotherapy | May 1, 2016

von Hohmann, N. | Reinhard, R. | Schnaidt, S. | +5

2

Treatment with rilpivirine does not alter plasma concentrations of the CYP3A substrates tadalafil and midazolam in humans

enthalten in: The journal of antimicrobial chemotherapy | 2016

von Hohmann, N. | Reinhard, R. | Schnaidt, S. | +5

3

Treatment with rilpivirine does not alter plasma concentrations of the CYP3A substrates tadalafil and midazolam in humans

enthalten in: The journal of antimicrobial chemotherapy | 2016

von Hohmann, N. | Reinhard, R. | Schnaidt, S. | +5

4

Understanding variability with voriconazole using a population pharmacokinetic approach: implications for optimal dosing

enthalten in: The journal of antimicrobial chemotherapy | 2014

von Dolton, M. | Mikus, G. | Weiss, J. | +2

5

Understanding variability with voriconazole using a population pharmacokinetic approach : implications for optimal dosing

in: The journal of antimicrobial chemotherapy | 2014

von Dolton, M. | Mikus, G. | Weiß, J.

6

Steady-state pharmacokinetics and metabolism of voriconazole in patients

enthalten in: The journal of antimicrobial chemotherapy | 2013

von Geist, M. | Egerer, G. | Burhenne, J. | +3

7

Steady-state pharmacokinetics and metabolism of voriconazole in patients

enthalten in: The journal of antimicrobial chemotherapy | 13 June 2013

von Geist, M. | Egerer, G. | Burhenne, J. | +3

1
[1]